Aurobindo Pharma Ltd
₹1676.80
+4.80
(+0.29%)
as on
🔔 Acquisition & Approval Alert
Aurobindo Pharma receives USFDA approval for generic epilepsy drug and completes acquisition of 80% stake in A1 Biochem CRO platform.
What are INDmoney investors doing with Aurobindo Pharma shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Investment activity on INDmoney
-35.94%
Investment activity in Aurobindo Pharma among INDmoney users has decreased by 35.94% over the last 30 days.
Among the most traded stocks
177th
Aurobindo Pharma was the 177th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
30 days
INDmoney investors hold Aurobindo Pharma shares for an average of 30 days.
Key Events for Aurobindo Pharma
Aurobindo Pharma Stock Performance
as on October 1, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,654.20₹1,700.70
1.35%
Downside
1.43%
Upside
52 Week's Low
52 Week's High
₹1,066.80₹1,740.0036.38%
Downside
3.77%
Upside
Aurobindo Pharma share price movements today
- Previous Close
- ₹1,672.00
- Open
- ₹1,677.90
- Volume
- 10.74L
- Upper Circuit
- ₹1,719.40
- Lower Circuit
- ₹1,619.40
- Day's Low - High
- ₹1,654.20 - ₹1,700.70
- 52 Week Low - High
- ₹1,066.80 - ₹1,740.00
Aurobindo Pharma Historical Returns
- 1 Month Return
- + 1.43 %
- 3 Month Return
- + 5.15 %
- 1 Year Return
- + 52.92 %
- 3 Year Return
- + 90.05 %
- 5 Year Return
- + 129.02 %
Aurobindo Pharma Fundamentals
as on October 1, 2026 at 4:01 pm IST
Market Cap
₹96,479.37 Cr
Return on Equity (ROE)
11.17
PE Ratio (TTM)
26.2
Return on capital employed (ROCE)
12.91
Industry PE ratio
51.84
Beta (LTM)
0.37
P/B Ratio
3.33
Dividend Yield
0.31
PEG Ratio
4.61
Quarterly Earnings Growth YOY
25.22
EPS (TTM)
60.31
Book Value
652.39
Aurobindo Pharma Stock Valuation
as on October 1, 2026 at 4:01 pm IST
Aurobindo Pharma in the last 5 years
Lowest (6.73x)
March 23, 2020
Today (26.20x)
October 1, 2026
Industry (51.84x)
October 1, 2026
Highest (27.59x)
December 21, 2023
Today’s Price to Earnings Ratio: 26.20x
Aurobindo Pharma Technical Analysis
Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.5 | |
CCI (20) | -54.07 | Neutral |
RSI (14) | 46.42 | Neutral |
Momentum (10) | 0 | Bullish |
ADI (14) | 50.31 | |
Ultimate Oscillator (7,14,28) | 12.51 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1668.4 | |
EMA (20) | 1667.44 | |
VWMA (20) | 1667.44 | |
SMA (50) | 1667.7 | |
EMA (50) | 1666.95 | |
SMA (200) | 1666.7 | |
EMA (200) | 1667.73 | |
KAMA (200) | 1667.65 | |
DEMA (200) | 1663.6 | Bullish |
Aurobindo Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 96,479.37 | 25.8% | 0.60 | 3,502 | 33,653 | |
| BUY | 6,995.13 | -12.39% | 0.00 | 413 | 2,013 | |
| BUY | 1,14,284.01 | 20.76% | 0.69 | 5,026 | 51,180 | |
| BUY | 57,035.00 | 3.23% | 0.00 | 1,414 | 6,445 | |
| BUY | 46,944.11 | 16.99% | 0.56 | 1,035 | 3,821 |
Market expectation of Aurobindo Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
62.96%
Buy
18.52%
Hold
18.52%
Sell
Aurobindo Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Aurobindo Pharma
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Aurobindo Pharma
Sorted by largest increase in holding, month-over-month.
No buying activity data available right now
Mutual Funds Exiting Aurobindo Pharma
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 SBI Large & Midcap Fund Direct Growth | ₹788.10 Cr | ₹103.76 Cr (-11.63%) | 1.91% |
 Quant Mid Cap Fund Growth Option Direct Plan | ₹822.11 Cr | ₹41.75 Cr (-4.83%) | 10.45% |
Aurobindo Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Aurobindo Pharma.
Aurobindo Pharma Ltd Earnings Results
Aurobindo Pharma Ltd’s net profit jumped 25.2% since last year same period to ₹1,032.56Cr in the Q1 2026-2027. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 12.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsAurobindo Pharma Ltd Dividends August,2025
In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.24%.
Read More about Dividends
Indices Featuring Aurobindo Pharma Stock
Check stock indices that include Aurobindo Pharma.
Insights on Aurobindo Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 51.82% to 51.88% in Jun 2026 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 15.24% to 16.38% in Jun 2026 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, AUROPHARMA stock has moved up by 52.9%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 7.97K Cr → 9.41K Cr (in ₹), with an average increase of 4.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, 824.75 Cr → 1.03K Cr (in ₹), with an average increase of 5.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.7% return, outperforming this stock by 5.8%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.7% return, outperforming this stock by 65.7%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 17.79% to 16.71% in Jun 2026 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.08% to 6.64% in Jun 2026 quarter
Aurobindo Pharma Stock Futures & Options Contracts
View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
Aurobindo Pharma Options
Aurobindo Pharma Futures
About Aurobindo Pharma Ltd
The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.
Revenue: ₹9,105.82Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1,032.03Cr as on June 2026 (Q1 FY27)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
| Organisation | Aurobindo Pharma Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K Ragunathan |
| E-voting on shares | Click here to vote |
FAQs
What is Aurobindo Pharma share price today?
Aurobindo Pharma share price today stands at ₹1676.8 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1700.7 and a low of ₹1654.2.
What is the 52 week high and 52 week low range for Aurobindo Pharma share?
Aurobindo Pharma touched a 52 week high of ₹1740 and a 52 week low of ₹1066.8. Aurobindo Pharma share price today i.e. is closed at ₹1676.8, which is -3.63% down from its 52 week high and 57.18% up from its 52 week low.
What is Aurobindo Pharma's market capitalisation today?
Aurobindo Pharma market capitalisation is ₹96,479.37 Cr as on .
How to buy Aurobindo Pharma shares?
To buy Aurobindo Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Aurobindo Pharma trading volume today?
Aurobindo Pharma trading volume is 10.74L as on . This means that 10.74L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Aurobindo Pharma shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest in Aurobindo Pharma has increased while investment activity has decreased over the past 30 days, and the average INDmoney investor holds the stock for 30 days. This reflects platform activity only and is not investment advice.